References

The development and application of NRICM101 and NRICM102 for the treatment of COVID-19

10.1016/j.jfma.2023.04.015 · 2023 · External reference

Efficacy analysis and research progress of complementary and alternative medicines in the adjuvant treatment of COVID-19

10.1186/s12929-023-00923-5 · 2023 · External reference

A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: a bedside-to-bench study

10.1016/j.biopha.2020.111037 · 2021 · External reference

Pharmacological mechanism of NRICM101 for COVID-19 treatments by combined network pharmacology and pharmacodynamics

10.3390/ijms232315385 · 2022 · External reference

Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis

10.1016/j.phrs.2022.106424 · 2022 · External reference

SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19

10.1007/s15010-023-02142-4 · 2024 · External reference

The role of IL-6 in coronavirus, especially in COVID-19

2022 · External reference

Unveiling COVID-19 secrets: harnessing cytokines as powerful biomarkers for diagnosis and predicting severity

10.2147/jir.s439217 · 2023 · External reference

Unresolved reference

2022 · External reference

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

10.1016/s0140-6736(20)30183-5 · 2020 · External reference

Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury

10.1093/nsr/nwaa037 · 2020 · External reference

NRICM101 ameliorates SARS-CoV-2–S1-induced pulmonary injury in K18-hACE2 mice model

10.3389/fphar.2023.1125414 · 2023 · External reference

Chinese herbal prescriptions for COVID-19 management: special reference to Taiwan Chingguan Yihau (NRICM101)

10.3389/fphar.2022.928106 · 2022 · External reference

Curbing COVID-19 progression and mortality with traditional Chinese medicine among hospitalized patients: a propensity score–matched analysis

2023 · External reference

The pharmacological efficacy of baicalin in inflammatory diseases

10.3390/ijms24119317 · 2023 · External reference

Houttuynia cordata inhibits lipopolysaccharide-induced rapid pulmonary fibrosis by upregulating IFN-γ and inhibiting the TGF-β1/Smad pathway

10.1016/j.intimp.2012.03.011 · 2012 · External reference

Isatis tinctoria L. derived petroleum ether extract mediates anti-inflammatory effects via inhibition of interleukin-6, interleukin-33 and mast cell degranulation

10.2340/00015555-3476 · 2020 · External reference

Trichosanthes kirilowii ethanol extract and cucurbitacin D inhibit cell growth and induce apoptosis through inhibition of STAT3 activity in breast cancer cells

10.1155/2013/975350 · 2013 · External reference

Pharmacology, toxicity, bioavailability, and formulation of magnolol: an update

2021 · External reference

The phenolic fraction of Mentha haplocalyx and its constituent linarin ameliorate inflammatory response through inactivation of NF-κB and MAPKs in lipopolysaccharide-induced RAW264.7 cells

10.3390/molecules22050811 · 2017 · External reference

Suppression of tumour necrosis factor-α by Schizonepeta tenuifolia water extract via inhibition of IκBα degradation and Jun N-terminal kinase/stress-activated protein kinase activation

10.1111/j.2042-7158.2010.01126.x · 2010 · External reference

Anti-inflammatory activity of mulberry leaf flavonoids in vitro and in vivo

10.3390/ijms23147694 · 2022 · External reference

Anti-inflammatory and antiosteoarthritis effects of Saposhnikovia divaricata ethanol extract: in vitro and in vivo studies

10.1155/2016/1984238 · 2016 · External reference

Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner

10.1189/jlb.0112038 · 2012 · External reference